ACM
TMDX icon

Abrams Capital Management’s Transmedics TMDX Stock Holding History

Abrams Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,499,859
Closed -$69.6M – 18
2020
Q4 		$69.6M Hold
3,499,859
– – 1.96% 14
2020
Q3 		$48.2M Hold
3,499,859
– – 1.52% 15
2020
Q2 		$62.7M Hold
3,499,859
– – 2.03% 16
2020
Q1 		$42.3M Hold
3,499,859
– – 1.66% 17
2019
Q4 		$66.5M Hold
3,499,859
– – 2.07% 15
2019
Q3 		$80.4M Hold
3,499,859
– – 2.25% 14
2019
Q2 		$87.8M Buy
+3,499,859
New +$95.5M 2.39% 14

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Abrams Capital Management's TMDX Position: Q1 2021 in Review

Abrams Capital Management sold out of Transmedics (TMDX) in Q1 2021, closing a stake of 3,499,859 shares — an estimated $69.6M sold.

Abrams Capital Management first reported a position in TMDX in Q2 2019 and held it in 7 quarters. The position peaked at $87.8M in Q2 2019. 107 funds tracked by Wall St. Rank hold TMDX as of Q1 2021.

  • Abrams Capital Management reported no remaining Transmedics position as of Q1 2021 after selling out during the quarter.
  • Abrams Capital Management sold 3,499,859 Transmedics shares in Q1 2021, an estimated $69.6M.
  • Abrams Capital Management first reported a position in Transmedics in Q2 2019 and held it in 7 quarters.
  • Abrams Capital Management's Transmedics position peaked at $87.8M in Q2 2019.
  • 107 funds tracked by Wall St. Rank held Transmedics as of Q1 2021.

Based on Abrams Capital Management's 13F filing for Q1 2021, filed 14 May 2021.